HighlightsSecond-quarter revenue of $643.3 millionSecond-quarter operating income of $34.3 millionSecond-quarter net income of $16.0 millionSecond-quarter adjusted EBITDA1 of $48.4 million […]
LA JOLLA, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and […]
Pro-forma(1) liquidity(2) of approximately $3.5 billion, including approximately $1.7 billion of consolidated cash on hand, $738 million of available revolver […]